Trainer Brendan Walsh has sent a letter to his owners contending that a post-race test that found multiple non-steroidal anti-inflammatory drugs in Saham after a race was the result of a veterinarian's error.
Kentucky stewards have suspended trainer Brendan Walsh for 10 days after multiple non-steroidal anti-inflammatory drugs were found in post-race tests of Saham after his third-place finish in the Transylvania Stakes.
F and F Stable's Best Play failed drug tests in back-to-back starts for trainer Luis Miranda in late 2014 and early 2015, a circumstance New York's state steward said he can't recall ever previously happening.
Trainer Rudy Rodriguez was handed a 25-day suspension and was fined $2,500 after two of his horses tested positive for the therapeutic drug flunixin, a non-steroidal anti-inflammatory drug also known as Banamine.
The New York State Gaming Commission has sanctioned trainer Bill Mott for a pair of medication overages in a single horse last fall, a decision the Racing Hall of Fame conditioner is appealing.
A council that makes recommendations on medication policies for the Kentucky Horse Racing Commission will go along with several changes in withdrawal times and threshold levels.
Saying the current withdrawal time on the books for flunixin (Banamine) could leave New York horsemen and veterinarians vulnerable to positive tests, the NYTHA is recommending extending the time by an additional eight hours.
The Racing Medication and Testing Consortium board of directors took several actions March 17 intended to further the process toward the nationwide adoption of uniform medication rules, penalties, and testing.
A Jan. 30 meeting of racing stakeholders in the Mid-Atlantic and Northeast regions showed how difficult it can be to achieve uniformity, even with the best intentions or most basic of regulations.
New York state regulators have imposed a 20-day suspension and $7,500 fine on top Aqueduct Racetrack trainer Rudy Rodriguez after flunixin was found in his horses at two separate races last year.
Lower thresholds for the pain reliever phenylbutazone, commonly known as Bute, in post-race tests of horses could be on the way in California in spite of objections from horsemen.
A spokeswoman for the New York State Racing and Wagering Board said Tuesday that a blood sample taken from a horse trained by Michael Dickinson was not lost but that there was an insufficient amount of the sample to be sent for independent testing.
Trainer Michael Dickinson said he is surprised that one of his horses, Lofty Call, tested positive for Flunixin at Belmont Park last summer, and that the stewards in the case "were fair and understanding."
The New York Racing Association issued a one-week suspension against trainer Michael Dickinson for the finding of flunixin in the post-race test of Lofty Call last summer.
Most Popular Stories
- Keeneland September Sale: 4,164 Yearlings
- Desormeaux Taken Off Mounts at Del Mar
- Korean-Bred Not Just a Novelty at F-T Sale
- WV Stakeholders Seek Racing Revenue Boost
- HRRN On-Site for Haskell, Saratoga Stakes
- Delaware Jockey Facing Charges After Shooting
- For Now, Nine Expected to Race in WV Derby
- American Pharoah Arrives at Monmouth
- Darley Closes Aiken Training Track Stable
- O'Neill Sets Del Mar Record With Five Wins